Logo image of GYL.OL

GYLDENDAL ASA (GYL.OL) Stock Fundamental Analysis

OSL:GYL - Euronext Oslo - NO0004288200 - Common Stock - Currency: NOK

428  0 (0%)

Fundamental Rating

2

Taking everything into account, GYL scores 2 out of 10 in our fundamental rating. GYL was compared to 51 industry peers in the Specialty Retail industry. GYL has a bad profitability rating. Also its financial health evaluation is rather negative. GYL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year GYL has reported negative net income.
GYL had a positive operating cash flow in the past year.
GYL had positive earnings in 4 of the past 5 years.
In the past 5 years GYL always reported a positive cash flow from operatings.
GYL.OL Yearly Net Income VS EBIT VS OCF VS FCFGYL.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

1.2 Ratios

GYL has a Return On Assets of -1.27%. This is in the lower half of the industry: GYL underperforms 61.11% of its industry peers.
The Return On Equity of GYL (-3.49%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.27%
ROE -3.49%
ROIC N/A
ROA(3y)0.32%
ROA(5y)1.3%
ROE(3y)0.77%
ROE(5y)3.17%
ROIC(3y)N/A
ROIC(5y)N/A
GYL.OL Yearly ROA, ROE, ROICGYL.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5

1.3 Margins

GYL's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 59.79%, GYL belongs to the best of the industry, outperforming 90.74% of the companies in the same industry.
In the last couple of years the Gross Margin of GYL has grown nicely.
The Profit Margin and Operating Margin are not available for GYL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.79%
OM growth 3Y-25.46%
OM growth 5Y-12.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.96%
GM growth 5Y1.73%
GYL.OL Yearly Profit, Operating, Gross MarginsGYL.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

GYL does not have a ROIC to compare to the WACC, probably because it is not profitable.
GYL has about the same amout of shares outstanding than it did 1 year ago.
GYL has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for GYL has been reduced compared to a year ago.
GYL.OL Yearly Shares OutstandingGYL.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
GYL.OL Yearly Total Debt VS Total AssetsGYL.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

GYL has an Altman-Z score of 2.11. This is not the best score and indicates that GYL is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of GYL (2.11) is comparable to the rest of the industry.
GYL has a debt to FCF ratio of 5.64. This is a neutral value as GYL would need 5.64 years to pay back of all of its debts.
GYL has a Debt to FCF ratio (5.64) which is in line with its industry peers.
GYL has a Debt/Equity ratio of 0.56. This is a neutral value indicating GYL is somewhat dependend on debt financing.
GYL has a Debt to Equity ratio (0.56) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.64
Altman-Z 2.11
ROIC/WACCN/A
WACC6.3%
GYL.OL Yearly LT Debt VS Equity VS FCFGYL.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

GYL has a Current Ratio of 0.96. This is a bad value and indicates that GYL is not financially healthy enough and could expect problems in meeting its short term obligations.
GYL's Current ratio of 0.96 is on the low side compared to the rest of the industry. GYL is outperformed by 74.07% of its industry peers.
GYL has a Quick Ratio of 0.96. This is a bad value and indicates that GYL is not financially healthy enough and could expect problems in meeting its short term obligations.
GYL has a worse Quick ratio (0.29) than 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.29
GYL.OL Yearly Current Assets VS Current LiabilitesGYL.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

1

3. Growth

3.1 Past

GYL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -354.62%.
Looking at the last year, GYL shows a decrease in Revenue. The Revenue has decreased by -1.36% in the last year.
GYL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.32% yearly.
EPS 1Y (TTM)-354.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.25%
Revenue 1Y (TTM)-1.36%
Revenue growth 3Y4.43%
Revenue growth 5Y6.32%
Sales Q2Q%0.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GYL.OL Yearly Revenue VS EstimatesGYL.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GYL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GYL.OL Price Earnings VS Forward Price EarningsGYL.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

GYL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. GYL is cheaper than 66.67% of the companies in the same industry.
GYL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. GYL is cheaper than 70.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.78
EV/EBITDA 6.02
GYL.OL Per share dataGYL.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800 1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

GYL has a Yearly Dividend Yield of 1.28%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.04, GYL pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.28, GYL pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

GYL has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-58%
EPS Next 2YN/A
EPS Next 3YN/A
GYL.OL Yearly Income VS Free CF VS DividendGYL.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

More info and screens

GYLDENDAL ASA

OSL:GYL (4/11/2025, 7:00:00 PM)

428

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.89%
Ins Owner ChangeN/A
Market Cap1.01B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Yearly Dividend7
Dividend Growth(5Y)0%
DP-58%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF 6.78
P/OCF 4.31
P/B 1.26
P/tB 1.92
EV/EBITDA 6.02
EPS(TTM)-13.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)63.14
FCFY14.75%
OCF(TTM)99.39
OCFY23.22%
SpS1136.66
BVpS339.36
TBVpS223.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.27%
ROE -3.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.79%
FCFM 5.55%
ROA(3y)0.32%
ROA(5y)1.3%
ROE(3y)0.77%
ROE(5y)3.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.22%
ROCE(5y)5.81%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.46%
OM growth 5Y-12.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.96%
GM growth 5Y1.73%
F-Score4
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.64
Debt/EBITDA 1.61
Cap/Depr 29.7%
Cap/Sales 3.19%
Interest Coverage N/A
Cash Conversion 84.27%
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.29
Altman-Z 2.11
F-Score4
WACC6.3%
ROIC/WACCN/A
Cap/Depr(3y)41.53%
Cap/Depr(5y)39.03%
Cap/Sales(3y)4.25%
Cap/Sales(5y)3.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-354.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.36%
Revenue growth 3Y4.43%
Revenue growth 5Y6.32%
Sales Q2Q%0.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-119.89%
EBIT growth 3Y-22.15%
EBIT growth 5Y-7.31%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.01%
FCF growth 3Y-22.97%
FCF growth 5Y7.09%
OCF growth 1Y-10.67%
OCF growth 3Y-15.24%
OCF growth 5Y10.19%